1. Targeting Leukocyte Trafficking in Inflammatory Bowel Disease

   • Nicola J. Wyatt
   • R. Alexander Speight
   • Christopher A. Lamb

   Leading Article 06 October 2021 Pages: 473 - 503

   

2. Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development

   • Scott B. Halstead

   Review Article 09 September 2021 Pages: 505 - 515

3. Advances in Immunotherapy for Diffuse Large B Cell Lymphoma

   • Geoffrey Shouse
   • Alex F. Herrera

   Review Article 15 July 2021 Pages: 517 - 528

4. Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy

   • Xue Yao
   • Sandro Matosevic

   Review Article 24 August 2021 Pages: 529 - 545

5. Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review

   • Hanna M. Tolonen
   • Jenni Falck
   • Marja Airaksinen

   Systematic Review Open access 16 August 2021 Pages: 547 - 561

   

6. Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product

   • Katariina M. Hutterer
   • Anna Ip
   • Jennifer Liu

   Original Research Article Open access 22 July 2021 Pages: 563 - 577

   

7. Comparative Risk of Arterial Thromboembolic Events Between Aflibercept and Ranibizumab in Patients with Maculopathy: A Population-Based Retrospective Cohort Study

   • Wan-Ju Annabelle Lee
   • Shih-Chieh Shao
   • Edward Chia-Cheng Lai

   Original Research Article 08 September 2021 Pages: 579 - 588